LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas

Anaplastic glioma is Grade III and the median overall survival is about 37.6 months. However, there are still other factors that affect the prognosis for anaplastic glioma patients due to variable overall survival. So we screened four-lncRNA signature (AGAP2-AS1, TPT1-AS1, LINC01198 and MIR155HG) fr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Wang, Wen, Yang, Fan, Zhang, Lu, Chen, Jing, Zhao, Zheng, Wang, Haoyuan, Wu, Fan, Liang, Tingyu, Yan, Xiaoyan, Li, Jiye, Lan, Qing, Wang, Jiangfei, Zhao, Jizong
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2016
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363582/
https://ncbi.nlm.nih.gov/pubmed/27764782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12624
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk